First Phase I Clinical Study Successfully Completed

by | Feb 10, 2015 | Latest News

Otifex   Therapeutics,   an   emerging   Australian   specialty  pharmaceutical      company    developing    a    new    treatment     for    the    most     common    cause    of   acquired  hearing         loss       in       childhood,       Otitis       Media    ...